Information about Pinxten Pharma Consulting
My details
*
*
*

Pinxten Pharma Consulting (SRL)

BE 1020.316.472

Kleine Ambachtslaan 10, 3990 Peer

Company information

Status
Active

Enterprise number

BE1020.316.472

VAT liability
Yes
Established
24-02-2025
Last balance sheet year
2025
Company size
Micro 0 FTE
Principal activity
Computer consultancy and computer facilities management activities
Health barometer
Credit limit
Detailpage

Are you looking for more information about this company?

  • Consult health at a glance

  • Choose quick insights or granular details

  • Get updates on important developments

Try for free Discover more

7-day free trial, no credit card required.

Financial data from Pinxten Pharma Consulting

2025
Profit/Loss € 40,866
Equity € 42,866
Gross margin € 63,790

Publications from Pinxten Pharma Consulting

Date Publication
26-02-2025 Rubric Constitution (New Juridical Person, Opening Branch, etc...) (NL)

Frequently asked questions

What is the VAT number of Pinxten Pharma Consulting?
The VAT number of Pinxten Pharma Consulting is BE 1020.316.472.
Wat is the PEPPOL ID of Pinxten Pharma Consulting?
The PEPPOL ID of Pinxten Pharma Consulting is 0208:1020316472. Log in or start a free trial to see the full overview.
When was Pinxten Pharma Consulting founded?
Pinxten Pharma Consulting was founded on 24-02-2025.
What is the address of Pinxten Pharma Consulting?
The current registered office of Pinxten Pharma Consulting is located at Kleine Ambachtslaan 10, 3990 Peer.
When was the last time Pinxten Pharma Consulting filed their annual financial statements?
The most recent financial statements of Pinxten Pharma Consulting were filed on 09-07-2026.
How many employees does Pinxten Pharma Consulting have?
There are currently no employees working at Pinxten Pharma Consulting or no workforce information is available.
What is the annual turnover of Pinxten Pharma Consulting?
At the time of its most recent financial statements, Pinxten Pharma Consulting did not publish any turnover figures. Pinxten Pharma Consulting reported a gross margin of €63,790.33.

Sources